When should I start broad-spectrum antibiotics?

doi:10.1007/s00134-024-07654-7

Editorial

. 2024 Nov;50(11):1908-1911.

doi: 10.1007/s00134-024-07654-7. Epub 2024 Sep 23.

When should I start broad-spectrum antibiotics?

Jean-François Timsit^{1

2

3}, Pieter Depuydt^{4

5}, Souha S Kanj^{6

7

8}

Affiliations

¹ Medical and infectious diseases ICU (MI2), AP-HP, Bichat Hospital, Paris, France. jean-francois.timsit@aphp.fr.
² Université Paris-Cité, IAME, INSERM, Paris, France. jean-francois.timsit@aphp.fr.
³ OUTCOME REA research network, Drancy, France. jean-francois.timsit@aphp.fr.
⁴ Department of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium.
⁵ Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
⁶ Division of Infectious Diseases, American University of Beirut Medical Center, Beirut, Lebanon.
⁷ Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
⁸ Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon.

PMID: 39311904
DOI: 10.1007/s00134-024-07654-7

Editorial

When should I start broad-spectrum antibiotics?

Jean-François Timsit et al. Intensive Care Med. 2024 Nov.

. 2024 Nov;50(11):1908-1911.

doi: 10.1007/s00134-024-07654-7. Epub 2024 Sep 23.

Authors

Jean-François Timsit^{1

2

3}, Pieter Depuydt^{4

5}, Souha S Kanj^{6

7

8}

Affiliations

¹ Medical and infectious diseases ICU (MI2), AP-HP, Bichat Hospital, Paris, France. jean-francois.timsit@aphp.fr.
² Université Paris-Cité, IAME, INSERM, Paris, France. jean-francois.timsit@aphp.fr.
³ OUTCOME REA research network, Drancy, France. jean-francois.timsit@aphp.fr.
⁴ Department of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium.
⁵ Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium.
⁶ Division of Infectious Diseases, American University of Beirut Medical Center, Beirut, Lebanon.
⁷ Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
⁸ Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon.

PMID: 39311904
DOI: 10.1007/s00134-024-07654-7

No abstract available

PubMed Disclaimer

References

1. Rhee C, Kadri SS, Dekker JP, Danner RL, Chen HC, Fram D, Zhang F, Wang R, Klompas M, Program CDCPE (2020) Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open 3:e202899 - DOI - PubMed - PMC
1. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Moller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47:1181–1247 - DOI - PubMed - PMC
1. Antimicrobial Resistance Collaborators (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399:629–655 - DOI
1. Mancuso G, Midiri A, Gerace E, Biondo C (2021) Bacterial antibiotic resistance: the most critical pathogens. Pathogens. https://doi.org/10.3390/pathogens10101310 - DOI - PubMed - PMC
1. Wiens J, Snyder GM, Finlayson S, Mahoney MV, Celi LA (2018) Potential adverse effects of broad-spectrum antimicrobial exposure in the intensive care unit. Open Forum Infect Dis 5:ofx270 - DOI - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer

[1] Rhee C, Kadri SS, Dekker JP, Danner RL, Chen HC, Fram D, Zhang F, Wang R, Klompas M, Program CDCPE (2020) Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open 3:e202899 - DOI - PubMed - PMC

[2] Rhee C, Kadri SS, Dekker JP, Danner RL, Chen HC, Fram D, Zhang F, Wang R, Klompas M, Program CDCPE (2020) Prevalence of antibiotic-resistant pathogens in culture-proven sepsis and outcomes associated with inadequate and broad-spectrum empiric antibiotic use. JAMA Netw Open 3:e202899 - DOI - PubMed - PMC

[3] Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Moller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47:1181–1247 - DOI - PubMed - PMC

[4] Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, McIntyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Moller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47:1181–1247 - DOI - PubMed - PMC

[5] Antimicrobial Resistance Collaborators (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399:629–655 - DOI

[6] Antimicrobial Resistance Collaborators (2022) Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399:629–655 - DOI

[7] Mancuso G, Midiri A, Gerace E, Biondo C (2021) Bacterial antibiotic resistance: the most critical pathogens. Pathogens. https://doi.org/10.3390/pathogens10101310 - DOI - PubMed - PMC

[8] Mancuso G, Midiri A, Gerace E, Biondo C (2021) Bacterial antibiotic resistance: the most critical pathogens. Pathogens. https://doi.org/10.3390/pathogens10101310 - DOI - PubMed - PMC

[9] Wiens J, Snyder GM, Finlayson S, Mahoney MV, Celi LA (2018) Potential adverse effects of broad-spectrum antimicrobial exposure in the intensive care unit. Open Forum Infect Dis 5:ofx270 - DOI - PubMed

[10] Wiens J, Snyder GM, Finlayson S, Mahoney MV, Celi LA (2018) Potential adverse effects of broad-spectrum antimicrobial exposure in the intensive care unit. Open Forum Infect Dis 5:ofx270 - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

When should I start broad-spectrum antibiotics?

Affiliations

When should I start broad-spectrum antibiotics?

Authors

Affiliations

Similar articles

References

Publication types

LinkOut - more resources

Full Text Sources